SEC Form 4 · accession 0001358403-19-000026
BELLICUM PHARMACEUTICALS, INC · BLCM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William Grossman
Officer — Sr. VP, Chief Medical Officer
Period of report
Feb 5, 2019
Accepted (ET)
Feb 7, 2019 · 4:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001358403
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 5, 2019 | F | 3,126 | $3.48 | D | 26,874 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the number of shares withheld by and surrendered to the Issuer on February 5, 2019, to satisfy tax withholding obligations that arose in connection with the vesting of the restricted stock units granted to the reporting person on February 5, 2018 for 30,000 shares, which vest in four equal annual installments on each anniversary of February 5, 2018.